WWA
ABBV icon

WCG Wealth Advisors’s AbbVie ABBV Stock Holding History

WCG Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
16,882
-197
-1% -$42.4K 0.1% 190
2026
Q1 		$3.71M Sell
17,079
-8
-0% -$1.77K 0.1% 186
2025
Q4 		$3.9M Buy
+17,087
New +$3.89M 0.11% 178
2024
Q2 		– Sell
-11,301
Closed -$2.06M – 276
2024
Q1 		$2.06M Sell
11,301
-2,401
-18% -$414K 0.17% 121
2023
Q4 		$2.12M Buy
13,702
+848
+7% +$124K 0.16% 127
2023
Q3 		$1.92M Buy
+12,854
New +$1.89M 0.14% 138
2022
Q4 		– Sell
-1,398
Closed -$218K – 153
2022
Q3 		$218K Sell
1,398
-149
-10% -$21.4K 0.03% 264
2022
Q2 		$237K Buy
+1,547
New +$236K 0.03% 238

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WCG Wealth Advisors's ABBV Position: Q2 2026 in Review

WCG Wealth Advisors reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $42.4K and leaving 16,882 shares worth $4.25M. The position accounts for 0.1% of the portfolio, ranked #190.

WCG Wealth Advisors first reported a position in ABBV in Q2 2022 and has held it in 8 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WCG Wealth Advisors held 16,882 shares of AbbVie worth $4.25M as of Q2 2026.
  • WCG Wealth Advisors sold 197 AbbVie shares in Q2 2026, an estimated $42.4K.
  • AbbVie made up 0.1% of WCG Wealth Advisors's portfolio in Q2 2026, its #190 holding.
  • WCG Wealth Advisors first reported a position in AbbVie in Q2 2022 and has held it in 8 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WCG Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.